Home ›
Organizations ›
DAYTON CLINICAL ONCOLOGY PROGRAM INC
DAYTON CLINICAL ONCOLOGY PROGRAM INC
OH · Disease Research · EIN 311100389
3
Executives Disclosed
$1.0M
Annual Revenue
$3.1M
Total Assets
DAYTON CLINICAL ONCOLOGY PROGRAM INC has 3 executives with disclosed compensation. The highest-paid executive, Mary Ontko (PRESIDENT/CEO), received peak total compensation of $112,491. The sector average for Disease Research executives is $215K.
Top Executive Compensation Over Time
Executive Compensation
| Name | Title | Peak Comp. | Latest Comp. | Years | vs. Household |
|---|---|---|---|---|---|
| Mary Ontko | PRESIDENT/CEO | $112K | $0 | 2017–2022 | 1.5x |
| Michelle Kinney | PRESIDENT/CEO | $76K | $0 | 2023–2024 | 1x |
| Howard M Gross | CHAIRPERSON | $25K | $0 | 2017–2024 | 0.3x |
Annual Summary
| Year | Executives | Avg. Comp. | Highest Comp. | Total Payroll |
|---|---|---|---|---|
| 2017 | 2 | $0 | $0 | $0 |
| 2018 | 2 | $0 | $0 | $0 |
| 2019 | 2 | $0 | $0 | $0 |
| 2020 | 2 | $0 | $0 | $0 |
| 2021 | 2 | $0 | $0 | $0 |
| 2022 | 2 | $0 | $0 | $0 |
| 2023 | 2 | $0 | $0 | $0 |
| 2024 | 2 | $0 | $0 | $0 |
Email Alerts
Get notified about DAYTON CLINICAL ONCOLOGY PROGRAM INC
Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.